Home › Funds › TANG CAPITAL MANAGEMENT LLC › LENZ

TANG CAPITAL MANAGEMENT LLC position in LENZ

LENZ THERAPEUTICS INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 451,114 shares of LENZ (LENZ THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.12% of its reported portfolio and ranking #39 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed LENZ holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)451.11K sh
Reported value held$2.56M
Portfolio Weight0.12%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's LENZ position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in LENZ in Q1 2024 at 547,616 shares (US$12.2M). The position peaked in Q3 2025 at 897,616 shares, worth US$41.8M. Across 10 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 451,114 shares valued at US$2.6M. Notable position changes include a 37% increase in Q2 2024 (shares rose 67% over the following quarter), a 48% trim in Q1 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 547.62K $12.23M New
Q2 2024 747.62K $12.93M Add
Q3 2024 766.94K $18.21M Add
Q4 2024 766.94K $22.14M Hold
Q1 2025 766.94K $19.72M Hold
Q2 2025 897.62K $26.31M Add
Q3 2025 897.62K $41.81M Hold
Q4 2025 865.17K $13.84M Reduce
Q1 2026 451.11K $4.13M Reduce
Q2 2026 451.11K $2.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LENZ and 13F data

LENZ (LENZ THERAPEUTICS INC) is a Health Care company. 24 other funds we track also report a position in LENZ — the largest reported positions include Alpha Wave Global, LP (US$20.5M), Versant Venture Management, LLC (US$15.1M), 72 Investment Holdings, LLC (US$5.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LENZ

All LENZ fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held LENZ?

TANG CAPITAL MANAGEMENT LLC has disclosed LENZ holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is TANG CAPITAL MANAGEMENT LLC's current position in LENZ?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 451.11K shares of LENZ (LENZ THERAPEUTICS INC), valued at $2.56M, representing 0.12% of its reported portfolio and ranking #39.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling LENZ?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in LENZ. The position peaked in Q3 2025 at 897.62K shares.

Which other funds hold LENZ?

Other major institutional holders of LENZ include Alpha Wave Global, LP, Versant Venture Management, LLC, 72 Investment Holdings, LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.